{
    "eid": "2-s2.0-85141800074",
    "title": "Comparison of Tacrolimus Intra-Patient Variability during 6\u201312 Months after Kidney Transplantation between CYP3A5 Expressers and Nonexpressers",
    "cover-date": "2022-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "CYP3A5",
        "genetic polymorphism",
        "immunosuppression",
        "intra-patient variability",
        "kidney transplantation",
        "tacrolimus",
        "therapeutic drug monitoring"
    ],
    "authors": [
        "Almas Nuchjumroon",
        "Somratai Vadcharavivad",
        "Wanchana Singhan",
        "Manorom Poosoonthornsri",
        "Wiwat Chancharoenthana",
        "Suwasin Udomkarnjananun",
        "Natavudh Townamchai",
        "Yingyos Avihingsanon",
        "Kearkiat Praditpornsilpa",
        "Somchai Eiam-Ong"
    ],
    "citedby-count": 1,
    "ref-count": 41,
    "ref-list": [
        "OPTN/SRTR 2019 Annual Data Report: Kidney",
        "Reduced exposure to calcineurin inhibitors in renal transplantation",
        "Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients",
        "Failure of calcineurin inhibitor (tacrolimus) weaning randomized trial in long-term stable kidney transplant recipients",
        "Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation",
        "Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation",
        "Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management",
        "High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation",
        "Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation",
        "Impact of tacrolimus intraindividual variability and CYP3A5 genetic polymorphism on acute rejection in kidney transplantation",
        "Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation",
        "Within-patient variability in tacrolimus blood levels predicts kidney graft loss and donor-specific antibody development",
        "High intrapatient tacrolimus variability is associated with worse outcomes in renal transplantation using a low-dose tacrolimus immunosuppressive regime",
        "A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation",
        "High intrapatient variability of tacrolimus concentrations predicts accelerated progression of chronic histologic lesions in renal recipients",
        "Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients",
        "Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure",
        "High intrapatient variability of tacrolimus levels and outpatient clinic nonattendance are associated with inferior outcomes in renal transplant patients",
        "Tacrolimus trough concentration variability and disparities in African American kidney transplantation",
        "Late intra-patient tacrolimus trough level variability as a major problem in kidney transplantation: A collaborative transplant study report",
        "High intrapatient variability in tacrolimus exposure calculated over a long period is associated with de novo donor-specific antibody development and/or late rejection in Thai kidney transplant patients receiving concomitant CYP3A4/5 inhibitors",
        "Therapeutic drug monitoring of tacrolimus-personalized therapy: Second consensus report",
        "Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I",
        "The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation",
        "CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearance",
        "CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipients",
        "Impact of CYP3A5 genetic polymorphism on intrapatient variability of tacrolimus exposure in Chinese kidney transplant recipients",
        "CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population",
        "Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration",
        "G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences",
        "Intrapatient variability of tacrolimus exposure in solid organ transplantation: A novel marker for clinical outcome",
        "Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women",
        "CYP3A5 polymorphisms in renal transplant recipients: Influence on tacrolimus treatment",
        "Novel polymorphisms associated with tacrolimus trough concentrations: Results from a multicenter kidney transplant consortium",
        "Impact of POR and CYP3A5 polymorphisms on trough concentration to dose ratio of tacrolimus in the early post-operative period following kidney transplantation",
        "The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients: A systematic review and meta-analysis",
        "Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: Comparison with similar data from other populations",
        "Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit",
        "Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: Toward updated genotype-based dosage guidelines",
        "Genomewide association study of tacrolimus concentrations in African American kidney transplant recipients identifies multiple CYP3A5 alleles"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199573",
            "affilname": "Faculty of Tropical Medicine, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199573",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}